Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Valproic Acid in the Induction of EBV Lytic Cycle Antigen Expression in Nasopharyngeal Carcinoma

NCT00181220 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT00181220
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00181220 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Valproic Acid in the Induction of EBV Lytic Cycle Antigen Expression in Nasopharyngeal Carcinoma
Lead sponsor
Johns Hopkins University
Phase
Phase 1
Overall status
Withdrawn
Start date
April 30, 2004
Completion date
September 30, 2006
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nasopharyngeal carcinoma